221 related articles for article (PubMed ID: 33313237)
1. A HPV16-related prognostic indicator for head and neck squamous cell carcinoma.
Zhang Q; Chen Y; Hu SQ; Pu YM; Zhang K; Wang YX
Ann Transl Med; 2020 Nov; 8(22):1492. PubMed ID: 33313237
[TBL] [Abstract][Full Text] [Related]
2. Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Chen YT; Yao JN; Qin YT; Hu K; Wu F; Fang YY
FEBS Open Bio; 2018 Aug; 8(8):1280-1298. PubMed ID: 30087832
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Oncogenic Targets by
Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
[TBL] [Abstract][Full Text] [Related]
4. Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Wei GG; Guo WP; Tang ZY; Li SH; Wu HY; Zhang LC
Pathol Res Pract; 2019 May; 215(5):963-976. PubMed ID: 30904360
[TBL] [Abstract][Full Text] [Related]
5. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
6.
Tomaszewska W; Kozłowska-Masłoń J; Baranowski D; Perkowska A; Szałkowska S; Kazimierczak U; Severino P; Lamperska K; Kolenda T
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944712
[TBL] [Abstract][Full Text] [Related]
7. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.
Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T
Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474
[No Abstract] [Full Text] [Related]
8. Identification of Antitumor
Minemura C; Asai S; Koma A; Kikkawa N; Kato M; Kasamatsu A; Uzawa K; Hanazawa T; Seki N
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886008
[TBL] [Abstract][Full Text] [Related]
9. Identification of
Tanaka N; Minemura C; Asai S; Kikkawa N; Kinoshita T; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946859
[TBL] [Abstract][Full Text] [Related]
10. MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma.
Wang QW; Sun YN; Tan LJ; Zhao JN; Zhou XJ; Yu TJ; Liu JT
Mol Biol Rep; 2023 Jun; 50(6):5307-5317. PubMed ID: 37155009
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
12. Identification of Tumor Suppressive Genes Regulated by
Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and potential mechanisms of
Zhao L; Tian C; Xiao E; Du J; Liang J; Chen X; Chi W
Open Med (Wars); 2020; 15(1):728-738. PubMed ID: 33336030
[TBL] [Abstract][Full Text] [Related]
14. Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell Carcinoma.
Huang Q; Shen YJ; Hsueh CY; Zhang YF; Yuan XH; Zhou YJ; Li JY; Lin L; Wu CP; Hu CY
Pathol Oncol Res; 2022; 28():1610699. PubMed ID: 36330052
[No Abstract] [Full Text] [Related]
15. The lncRNA XIST/miR-29b-3p/COL3A1 axis regulates central carbon metabolism in head and neck squamous cell carcinoma and is associated with poor tumor prognosis.
Li Q; Miao J; Shi N; Lin C; Hu X; Shen Y
Ann Transl Med; 2023 Feb; 11(4):165. PubMed ID: 36923098
[TBL] [Abstract][Full Text] [Related]
16. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
[TBL] [Abstract][Full Text] [Related]
17. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
18. Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.
Nunez Lopez YO; Victoria B; Golusinski P; Golusinski W; Masternak MM
Rep Pract Oncol Radiother; 2018; 23(1):6-20. PubMed ID: 29187807
[TBL] [Abstract][Full Text] [Related]
19. Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma.
Zhang T; Zhu X; Sun Q; Qin X; Zhang Z; Feng Y; Yan M; Chen W
Front Oncol; 2021; 11():616372. PubMed ID: 34336638
[TBL] [Abstract][Full Text] [Related]
20. HPV16 E6 enhances the radiosensitivity in HPV-positive human head and neck squamous cell carcinoma by regulating the miR-27a-3p/SMG1 axis.
Long D; Xu L; Deng Z; Guo D; Zhang Y; Liu Z; Zhang C
Infect Agent Cancer; 2021 Aug; 16(1):56. PubMed ID: 34389030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
